New maintenance treatment for acute myeloid leukemia prolongs the lives of patients

Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial.

from Top Health News -- ScienceDaily https://ift.tt/3iMlWN1